Edition:
United States

Neurosearch A/S (NEUR.CO)

NEUR.CO on Copenhagen Stock Exchange

3.50DKK
10:59am EDT
Change (% chg)

kr.-0.02 (-0.57%)
Prev Close
kr.3.52
Open
kr.3.52
Day's High
kr.3.54
Day's Low
kr.3.46
Volume
15,487
Avg. Vol
46,495
52-wk High
kr.4.49
52-wk Low
kr.2.20

Summary

Name Age Since Current Position

Karin Garre

60 2013 Independent Chairman of the Board

Allan Andersen

72 2013 Chief Executive Officer, Director

Christian Lundgren

51 2013 Director

Biographies

Name Description

Karin Garre

Ms. Karin Garre has served as Independent Chairman of the Board at NeuroSearch A/S since December 9, 2013. She was Executive Vice President of Drug Development and Chief Development Officer at the Company from 2010 until December 9, 2013. She is Executive Head at Psychiatric Center of Copenhagen. She has 25 years of executive experience from the pharmaceutical industry and management experience from Stem Care A/S and LTC A/S, among others. She holds a Doctor of Medicine degree.

Allan Andersen

Mr. Allan Andersen has been appointed Chief Executive Officer of NeuroSearch A/S, effective as of December 1, 2013. He has been Member of the Company's Board since May 1989. He was Chairman of the Company's Board of Directors from January 4, 2013 till December 1, 2013. He is also Member of the Board of Directors at NsGene A/S and Member of the Management of AA Consult ApS, Allan Consulting EOOD, AA Construction EOOD, Provadia Cheese OOD, Jeravna Development EOOD. In addition, he acts as Chairman of the Board of Directors at of Nordicom A/S. He is Chief Executive Officer of AA Consult ApS. He has more than 30 years of broad experience from various Boards of Directors and extensive financial knowledge as well as experience with investors in the biotech industry.

Christian Lundgren

Mr. Christian Lundgren has been Member of the Board of Directors of Neurosearch A/S since January 4, 2013. He was Chairman of the Company's Board from December 1, 2013 until December 9, 2013. He is Lawyer and Partner at the law firm of Kromann Reumert, and Member of the Board of Directors of Det Nissenske Familiefond. He holds a Law degree from Koebenhavns Universitet from 1991. He has many years of experience in advising on restructuring and other transactions involving listed companies and depth knowledge of the biotech industry.

Basic Compensation

Name Fiscal Year Total

Karin Garre

--

Allan Andersen

--

Christian Lundgren

--
As Of 

Options Compensation